Unlock instant, AI-driven research and patent intelligence for your innovation.

Acyclic nucleoside lead compound and its preparation method and application in pharmacy

A cyclic nucleoside compound, nucleoside compound technology, applied in organic chemistry, anti-tumor drugs, drug combinations, etc., can solve the problem of less research on anti-tumor activity of acyclic nucleoside compounds

Active Publication Date: 2022-05-20
HENAN NORMAL UNIV +1
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, acyclic nucleoside compounds are an important class of antiviral drugs on the market, but there are relatively few studies on the antitumor activity of acyclic nucleoside compounds

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Acyclic nucleoside lead compound and its preparation method and application in pharmacy
  • Acyclic nucleoside lead compound and its preparation method and application in pharmacy
  • Acyclic nucleoside lead compound and its preparation method and application in pharmacy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042]

[0043] Representative test operation: In the reaction flask, add 6-chloropurine (30.9mg, 0.2mmol), L-proline (2.3mg, 0.02mmol) and benzoic acid (2.4mg, 0.02mmol) in sequence, then add 1.5 mL of methanol, and finally trans-2-dodecenal (64.4 μL, 0.3 mmol) was added to the reaction tube, and reacted at room temperature for 24 h. The reaction was detected by TLC (petroleum ether / ethyl acetate=1.5 / 1). After the reaction was completed, it was transferred to an ice-water bath. After the temperature dropped, sodium borohydride (22.7 mg, 0.6 mmol) was slowly added for about 10 minutes. The reaction was detected by TLC (petroleum ether / ethyl acetate=1.5 / 1). After the reaction, add saturated ammonium chloride solution to quench the reaction, add water after vacuum distillation, extract with ethyl acetate, dry the organic phase with anhydrous sodium sulfate, and perform column chromatography on petroleum ether / ethyl acetate (3:1) to obtain white Solid 9b; Mp: 101-102 °C. 1 H...

Embodiment 2

[0099] Synthesis of chiral nucleoside compounds 7b-9b (R-andS-): The general operation is as follows: In the reaction tube, add α,β-unsaturated aldehyde (0.3mmol), catalyst (0.02mmol), benzoic acid (0.02 mmol) and 1.0 mL of anhydrous toluene, stirred at room temperature for 2 h, cooled to -30 °C, added 6-chloropurine (0.2 mmol) into the reaction tube under stirring conditions, and reacted at -30 °C for 48 h. Petroleum ether / ethyl acetate=1.5 / 1 detection reaction. After the reaction was completed, 0.5 mL of methanol was added to the mixed solution while it was kept warm, and then sodium borohydride (0.6 mmol) was added slowly. Slowly raise the temperature to 0°C and react for 30 minutes, and detect the reaction with petroleum ether / ethyl acetate=1.5:1. After the reaction was completed, quenched with saturated ammonium chloride, distilled under reduced pressure, added water, extracted with ethyl acetate, dried over anhydrous sodium sulfate, and subjected to column chromatograph...

Embodiment 3

[0118] The present invention synthesizes a series of racemization, R-configuration and S-configuration acyclic nucleoside compounds by using the above method, and tests the cell activity of these compounds on tumor cells by MTT method. The cellular viability of synthetic compounds was assessed using the 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay, with 5 × 10 3 Cells were seeded into 96-well plates and cultured at 37°C / 5% CO 2 24h in the incubator. Then, they were treated with various gradient dilutions of the compound, the control drug 5-FU or the diluent (DMSO) for 48 hours. Replace the medium containing the compound, 5-FU or diluent (DMSO) with 180 μL of fresh medium and 20 μL of MTT solution (5 mg / mL PBS solution), placed at 37 ° C, 5% CO 2 Then, the medium containing MTT was replaced with DMSO (150 μL), and the absorbance of each blank was measured at a wavelength of 570 nm with a microplate reader (Multiskan FC, Thermo), and each concentra...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a novel acyclic nucleoside compound with the following general structure and significant anti-tumor activity, a synthesis method and its application in the research and development of anti-tumor drugs, and belongs to the technical field of medicinal chemistry. The present invention also includes the application of the compound, its pharmaceutical salt and its compound medicine in the preparation of medicine for preventing or treating tumor-related diseases. In the present invention, a series of acyclic nucleoside compounds with different substituents at the 2 / 6 / 8 position of purine and the 1' position of the purine side chain are synthesized through aza-Michael addition reaction, allyl amination reaction and other reactions, including racemization body, R-configuration and S-configuration, the general structure is (* is a chiral center). The compounds provided by the present invention or their pharmaceutically acceptable salts can effectively inhibit the growth of tumor cells in vitro and in vivo, and can be used to prepare medicines for preventing or treating tumor-related diseases. The tumor-related diseases include benign and malignant tumors and other diseases caused by tumors.

Description

technical field [0001] The present invention relates to screening of acyclic nucleoside compounds, in particular to acyclic nucleoside compounds with significant antitumor activity, synthesis method, antitumor activity in vivo and in vitro, and the compounds and their acceptable pharmaceutical salts or components thereof The application of the compound drug of No. 1 in the preparation of drugs for the prevention and treatment of tumor-related diseases belongs to the technical field of medicinal chemistry. Background technique [0002] Malignant tumors seriously threaten human life and health, and are one of the main causes of human death. The research and development of anticancer drugs has always been one of the important directions in drug development. Artificially synthesized nucleoside compounds are similar in structure to natural nucleoside compounds, and can inhibit the replication of viruses or tumor cells after entering the human body to achieve the purpose of anti-...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D487/04A61P35/00
CPCC07D487/04A61P35/00Y02A50/30
Inventor 郭海明王洋郝二军李恭欣梁玉茹谢明胜王东超
Owner HENAN NORMAL UNIV
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More